In conclusion, the conversion of bile acids mediated by the microbiota is pivotal in maintaining glucose homeostasis, lipid metabolism, and energy balance through the FXR and TGR5 signaling pathways, offering novel insights and targets for the treatment of metabolic diseases [324]. Here, NR1H4 is linked to metabolic disease.